相关实验视频

Updated: May 29, 2025

Site Specific Lysine Acetylation of Histones for Nucleosome Reconstitution using Genetic Code Expansion in Escherichia coli

Site Specific Lysine Acetylation of Histones for Nucleosome Reconstitution using Genetic Code Expansion in Escherichia coli

Published on: December 26, 2020

cGAS-STING向为肺部疾病提供治疗选择

Yu Wang¹, Xuan Zhang², Weixue Wang¹

¹Department of Geriatrics, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing, 100049, China.

|February 7, 2025

概括

循环GMP/AMP合成酶 (cGAS) 刺激干扰素基因 (STING) 途径对免疫力至关重要,但当过度活跃时会导致肺部疾病. 针对这种途径的小分子为炎症性肺部疾病提供了新的治疗选择.

科学领域:

免疫学免疫学免疫学
分子生物学分子生物学
肺部病理学肺部病理学

背景情况:

循环GMP/AMP (cGAMP) 合成酶 (cGAS) 和干扰素基因刺激器 (STING) 途径是先天免疫系统的关键组成部分,对微生物和自我DNA作出反应.
cGAS-STING轴的异常激活与自身免疫性疾病,无菌性炎症和细胞衰老有关.
慢性cGAS-STING激活越来越被认为是各种炎症性肺部疾病的驱动因素.

研究的目的:

审查cGAS-STING通路的基本组件和信号级联.
讨论cGAS-STING通过哪些机制对肺部疾病的发病有所贡献.
总结新兴的小分子抑制剂,针对cGAS-STING通路,用于肺部疾病的潜在治疗应用.

主要方法:

对cGAS-STING路径的文献综述.
对cGAS-STING在肺炎中的作用的研究分析.
对抑制cGAS-STING的生物活性小分子化合物的汇编和审查.

主要成果:

cGAS-STING通路在免疫和疾病中起着双重作用,特别是在肺部.
特定的分子机制将cGAS-STING激活与肺炎和疾病进展联系起来.
已经确定了几种针对cGAS-STING的小分子抑制剂具有潜在的治疗疗效.

结论:

向cGAS-STING通路代表了管理炎症性肺部疾病的有前途的治疗策略.
对cGAS-STING抑制剂的进一步研究可能会导致肺纤维化和自身免疫性肺部疾病等疾病的新治疗方法.
了解cGAS-STING在肺病理中的复杂作用,为药物开发开辟了新的途径.

关键词:

敌对者的敌人敌对者的敌人肺部疾病肺部疾病刺痛是一种刺痛.cGAS 是一个气体.

更多相关视频

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

Design of a Biocompatible Drug-Eluting Tracheal Stent in Mice with Laryngotracheal Stenosis

Design of a Biocompatible Drug-Eluting Tracheal Stent in Mice with Laryngotracheal Stenosis

Published on: January 21, 2020

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...